446 related articles for article (PubMed ID: 23723452)
1. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
[TBL] [Abstract][Full Text] [Related]
2. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
Leal I; Dos Santos TD; Gilli S; Castilho L
Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
[TBL] [Abstract][Full Text] [Related]
3. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
4. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
Israelyan N; Vege S; Friedman DF; Zhang Z; Uter S; Fasano RM; Yee M; Piccone C; Kelly S; Hankins JS; Zheng Y; Westhoff CM; Chou ST
Transfusion; 2024 Mar; 64(3):526-535. PubMed ID: 38289184
[TBL] [Abstract][Full Text] [Related]
5. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
6. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
8. The role of molecular immunohematology in sickle cell disease.
Chou ST; Westhoff CM
Transfus Apher Sci; 2011 Feb; 44(1):73-9. PubMed ID: 21277259
[TBL] [Abstract][Full Text] [Related]
9. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program.
Vege S; Westhoff CM
Immunohematology; 2006; 22(3):143-7. PubMed ID: 17105364
[TBL] [Abstract][Full Text] [Related]
12. Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.
Karafin MS; Field JJ; Gottschall JL; Denomme GA
Transfusion; 2015 Jun; 55(6 Pt 2):1399-406. PubMed ID: 25757390
[TBL] [Abstract][Full Text] [Related]
13. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ
Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia.
Al-Asmari B; Baothman A; Almohammadi M; Aljuaid M; Jastaniah W
J Pediatr Hematol Oncol; 2024 Jul; 46(5):e284-e289. PubMed ID: 38857199
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
18. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
Fasano RM; Chou ST
Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
[TBL] [Abstract][Full Text] [Related]
19. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
Hindawi S; Badawi M; Elfayoumi R; Elgemmezi T; Al Hassani A; Raml M; Alamoudi S; Gholam K
Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130
[TBL] [Abstract][Full Text] [Related]
20.
Chou ST; Evans P; Vege S; Coleman SL; Friedman DF; Keller M; Westhoff CM
Blood; 2018 Sep; 132(11):1198-1207. PubMed ID: 30026182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
